Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient

Haematologica. 1990 Jul-Aug;75(4):394-6.

Abstract

A 47-year-old woman received an allogeneic bone marrow infusion because of chronic myeloid leukemia. Two months after the transplant she developed an interstitial pneumonia: bronchoalveolar lavage yielded cytomegalic cells with intranuclear bodies, and cytomegalovirus DNA was detected by in situ hybridization techniques. Ganciclovir and standard high-dose immunoglobulins were administered to the patient with resolution of the pneumonia. No relapse of pneumonia was observed after a 4-month follow-up. It seems that the favorable outcome of the potentially fatal pneumonia observed in this patient might be related to early diagnosis, and prompt administration of ganciclovir and standard high-dose immunoglobulins.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow Transplantation* / adverse effects
  • Combined Modality Therapy
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / therapy*
  • Female
  • Ganciclovir / therapeutic use*
  • Humans
  • Immunization, Passive*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Middle Aged
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / etiology
  • Pneumonia, Viral / therapy*
  • Pulmonary Fibrosis / drug therapy
  • Pulmonary Fibrosis / etiology
  • Pulmonary Fibrosis / therapy*

Substances

  • Ganciclovir